A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults
Clinical trial NCT06360874 · UNKNOWN
Trial details
- NCT number
- NCT06360874
- Sponsor
- Shenzhen NewDEL Biotech, Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-09
- Primary completion
- 2024-12-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.